BSEKimia Biosciences LtdMediumNegative
Announced Thu, 19 Feb · 21:58 IST

Resignation of Additional Director(in the category of Executive Director)

Kmp ResignedManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mr. Kaku Vijaya Shekhar Reddy (DIN: 00800172), who served as Additional Director in the Executive Director category at Kimia Biosciences Ltd, has resigned with effect from February 18, 2026 citing personal reasons. The company accepted his resignation from the close of business hours on February 19, 2026. The disclosure was filed under SEBI LODR Regulation 30 by Company Secretary Pallavi Garg. In his resignation letter, Mr. Reddy mentioned that the decision was made after considerable thought and reflection, though he remains deeply committed to the pharmaceutical industry overall.

Likely market impact

The exit of an Executive Director — a Key Managerial Personnel — for personal reasons may briefly raise governance questions for this small-cap pharma company, but no operational discontinuity or financial concern is flagged. Investors should watch for a replacement appointment disclosure in the coming weeks.